US Congress House Bill 406 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 20 2015 - 25% progression, died in committee
Action: 2015-01-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Combination Drug Development Incentive Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to provide a five-year marketing exclusivity period to a new drug approved by the Food and Drug Administration that is a novel combination of active ingredients. The application for the combination drug must contain reports of new clinical investigations that are essential to approval and were conducted or sponsored by the applicant. Currently, a new drug that includes an active ingredient that has already been approved is provided a three-year marketing exclusivity period.

Combination Drug Development Incentive Act of 2015

Rep. Jason Chaffetz [R-UT]

Date	Chamber	Action
2015-01-23	House	Referred to the Subcommittee on Health.
2015-01-20	House	Referred to the House Committee on Energy and Commerce.
2015-01-20	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/406/all-info
Text	https://www.congress.gov/114/bills/hr406/BILLS-114hr406ih.pdf